Anti-TNF Therapy Tied to Better Outcomes in IBD Patients With COVID-19 Anti-TNF Therapy Tied to Better Outcomes in IBD Patients With COVID-19
In patients with inflammatory bowel disease who contracted COVID-19 infection, anti-TNF therapies were associated with more favorable outcomes than corticosteroids or mesalamine in a systematic review and analysis.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Source Type: news
More News: Asacol | Corticosteroid Therapy | COVID-19 | Gastroenterology | Infectious Diseases | Inflammatory Bowel Disease | Lialda